A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation
Qingyi He,2,* Xiaohui Wang,3,* Xing Zhang,4 Huifang Han,4 Baosan Han,5 Jianzhong Xu,2 Kanglai Tang,2 Zhiren Fu,1 Hao Yin1,4 1Department of Surgery, Organ Transplant Center, Shanghai Changzheng Hospital, Shanghai Second Military Medical School, 2Department of Orthopedic Surgery, Southwest Hospital, T...
Guardado en:
Autores principales: | He Q, Wang X, Zhang X, Han H, Han B, Xu J, Tang K, Fu Z, Yin H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eaec1f859f144384be75684d0f32858b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor Therapy
por: Wang J, et al.
Publicado: (2021) -
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
por: Yuan Z, et al.
Publicado: (2018) -
Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering
por: Fu W, et al.
Publicado: (2014) -
Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67
por: Cui M, et al.
Publicado: (2020) -
Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery
por: Zhan Q, et al.
Publicado: (2013)